Overall rank by patents
#26,944
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
North & South Brother Pharmacy Investment Company Limited
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, active 2019–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
10
Total patents granted
6
CPC technology areas
17.3
Avg claims per patent
+300%
5-year filing velocity
The verdict
North holds 10 US patents across 6 technology areas, rank #26,944 of 50,000 tracked assignees.
- #26,944
- of 50,000 US assignees by volume
- Top 77%
- by Innovation Score (27.3/100)
- 17.3
- avg claims per patent
- +300%
- filing velocity, last 5 yrs
Portfolio overview
North & South Brother Pharmacy Investment Company Limited has been granted 10 US utility patents between 2019 and 2020, placing North & South Brother Pharmacy Investment Company Limited at rank #26,944 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, North & South Brother Pharmacy Investment Company Limited is one of the more focused assignees in the PatentsView dataset. By volume, North sits between NO Screw Ltd. (10 patents, rank #26,940) and Novatron OY (10 patents, rank #26,948) - the closest US assignees by grant volume. The composite Innovation Score of 27.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 2 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. North & South Brother Pharmacy Investment Company Limited's 17.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark North & South Brother Pharmacy Investment Company Limited against peers pursuing similar technology classes.
Who files at North's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- NO Screw
NO SCREW LTD.
10 patents
- NOA
NOA, Inc.
10 patents
- Noble Drilling A/S
NOBLE DRILLING A/S
10 patents
- NOKE
NOKE, INC.
10 patents
- Novabiotics
NOVABIOTICS LIMITED
10 patents
- Novabone Products
NOVABONE PRODUCTS, LLC
10 patents
- Novastep
NOVASTEP
10 patents
- Novatron OY
NOVATRON OY
10 patents
- North & South Bro… ◀
NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
10 patents
What this shows North holds 10 patents at rank #26,944, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near North
By rank, the assignees closest to #26,944 in granted patent volume.
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in North's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
North's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 77% higher than 23% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 2 | 20.0% |
| 2020 | 8 | 80.0% |
Which technologies does North & South Brother Pharmacy Investment Company Limited patent most?
Top 6 of 6 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does North & South Brother Pharmacy Investment Company Limited hold?
North & South Brother Pharmacy Investment Company Limited holds 10 US granted patents filed between 2019 and 2020, spanning 6 technology areas.
What is North & South Brother Pharmacy Investment Company Limited's Innovation Score?
North & South Brother Pharmacy Investment Company Limited has an Innovation Score of 27.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does North & South Brother Pharmacy Investment Company Limited focus on?
North & South Brother Pharmacy Investment Company Limited's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 10 patents. The company has filed patents in 6 CPC subclasses total.
Is North & South Brother Pharmacy Investment Company Limited's patent filing rate increasing or decreasing?
North & South Brother Pharmacy Investment Company Limited's recent filing velocity is +300% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for North & South Brother Pharmacy Investment Company Limited's patents?
North & South Brother Pharmacy Investment Company Limited's patents average 17.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the North & South Brother Pharmacy Investment Company Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
North's 10 grants land it in the top 77% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - North ranks #26,944 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.